The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway

Retraction in: /10.3892/mmr.2023.13127

  • Authors:
    • Ting Li
    • Qingwen Zeng
    • Xingming Chen
    • Guojiang Wang
    • Haiqing Zhang
    • Aihua Yu
    • Hairui Wang
    • Yang Hu
  • View Affiliations

  • Published online on: April 16, 2018     https://doi.org/10.3892/mmr.2018.8887
  • Pages: 8385-8390
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Acne rosacea is a type of chronic dermatosis with the characteristics of erubescence, angiotelectasis and pustule formation. However, current treatment methods are limited due to the side effects. Artesunate demonstrated a promising therapeutic efficacy with a high safety margin. HaCaT cells were treated with antibacterial peptide LL‑37 to simulate rosacea caused by Demodex folliculorum (D. folliculorum) infection. Cell Counting kit 8 and flow cytometry assays were performed to measure cellular proliferation, apoptosis, the stage of the cell cycle and reactive oxygen species generation in order to determine the level of cell damage. Then the damaged cells were treated with different concentrations of artesunate and doxycycline to determine the therapeutic effect of artesunate. Pro‑inflammatory cytokines tumor necrosis factor‑α (TNF‑α), interleukin (IL)‑6, IL‑8 and C‑C motif chemokine 2 (MCP‑1) were measured using an ELISA, while western blotting was used to detect the expression of Janus kinase 2 (JAK2) and signal transducer and transcription activator (STAT3). As a result, LL‑37 treated HaCaT cells decreased in cell viability, had an increased apoptotic rate and cell cycle arrest, indicating that cell damage caused by rosacea was simulated. In addition, upregulated concentrations of the pro‑inflammatory cytokines TNF‑α, IL‑6, IL‑8 and MCP‑1 were attenuated in the artesunate group in a dose‑dependent fashion, indicating the therapeutic effect of artesunate. Furthermore, higher concentrations of artesunate exhibited an improved effect compared with the doxycycline group. In addition, increased expression levels of JAK2 and STAT3 following treatment with LL‑37 suggested that rosacea caused by D. folliculorum infection may lead to inflammation through the JAK/STAT signaling pathway. In conclusion, the potential mechanism by which damage occurs in rosacea was revealed and a promising therapeutic method against rosacea was demonstrated.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 17 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li T, Zeng Q, Chen X, Wang G, Zhang H, Yu A, Wang H and Hu Y: The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway Retraction in /10.3892/mmr.2023.13127. Mol Med Rep 17: 8385-8390, 2018.
APA
Li, T., Zeng, Q., Chen, X., Wang, G., Zhang, H., Yu, A. ... Hu, Y. (2018). The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway Retraction in /10.3892/mmr.2023.13127. Molecular Medicine Reports, 17, 8385-8390. https://doi.org/10.3892/mmr.2018.8887
MLA
Li, T., Zeng, Q., Chen, X., Wang, G., Zhang, H., Yu, A., Wang, H., Hu, Y."The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway Retraction in /10.3892/mmr.2023.13127". Molecular Medicine Reports 17.6 (2018): 8385-8390.
Chicago
Li, T., Zeng, Q., Chen, X., Wang, G., Zhang, H., Yu, A., Wang, H., Hu, Y."The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway Retraction in /10.3892/mmr.2023.13127". Molecular Medicine Reports 17, no. 6 (2018): 8385-8390. https://doi.org/10.3892/mmr.2018.8887